StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) shareholders

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30524% above fair value
$63.65−0.23 (-0.36%)

Close on Nov 17, 2026Market cap $1.82BP/E 163.2Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
74.0%
21M of 29M shares
Institutional holders
165
55 new, 5 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
0 buys · 36 sales
Net sold $35.01M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Opaleye Management, Inc.2,672,50010.34%13G (passive) amendmentSep 9, 2024
Opaleye Management Inc.
Joint filing with Silverman James (8.54%), Opaleye, L.P. (8.47%)
2,440,0008.54%13G (passive) amendmentSep 30, 2026
EcoR1 Capital, LLC
Joint filing with Oleg Nodelman (7.70%), EcoR1 Capital Fund Qualified, L.P. (7.20%)
1,981,0037.70%13G (passive) amendmentDec 31, 2024
BlackRock, Inc.1,882,4106.90%13G (passive) amendmentJun 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ETONValueChange% of portfolio
Opaleye Management Inc.2,860,00010.01%$103.53M–9.38%
Nantahala Capital Management, LLC2,351,9028.23%$85.14M+1,175,9511.41%
EcoR1 Capital, LLC2,171,9387.60%$78.62M–3.82%
BlackRock, Inc.1,895,8336.63%$68.63M+178,5470.00%
Vanguard Capital Management LLC976,5703.42%$35.35M−17,5190.00%
Morgan Stanley767,9722.69%$27.80M+290,0150.00%
State Street Corp701,7862.46%$25.40M+171,5710.00%
Geode Capital Management, LLC652,3032.28%$23.62M+74,6370.00%
Oberweis Asset Management Inc/501,6001.75%$18.16M+62,3000.38%
National Philanthropic Trust492,1121.72%$17.81M–0.26%
Westside Investment Management, Inc.431,1601.51%$15.61M−36,7552.05%
Pillsbury Lake Capital LLC387,1571.35%$14.02M+22,2033.83%
Nuveen, LLC375,7071.31%$13.60M+317,7570.00%
Bnp Paribas Arbitrage, Snc322,4661.13%$11.67M+20,3580.00%
Woodline Partners LP310,8791.09%$11.25M+140,1800.03%
Thompson Siegel & Walmsley LLC297,2321.04%$10.76M−108,8570.19%
Northern Trust Corp255,8490.90%$9.26M+18,0170.00%
Marshall Wace, Llp249,1820.87%$9.02M+166,4610.01%
Panoramic Capital, LLC208,1920.73%$7.54M+23,1923.24%
Vanguard Portfolio Management LLC194,5910.68%$7.04M+42,8430.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202616521M74.0%55 / 5836 / 55M1M
Q1 202611618M62.2%30 / 3632 / 173M1M
Q4 202510416M57.4%21 / 2837 / 191M3M
Q3 202510319M64.9%27 / 2628 / 113M1M
Q2 20258717M59.7%26 / 3519 / 255M2M
Q1 20258615M51.1%26 / 2922 / 113M2M
Q4 20247114M47.7%27 / 2711 / 34M1M
Q3 20244810M35.0%13 / 109 / 92M1M
Q2 20244510M34.5%7 / 616 / 63M0M
Q1 2024448M26.9%2 / 1313 / 131M0M
Q4 2023568M26.8%14 / 199 / 81M1M
Q3 2023507M24.1%22 / 105 / 51M1M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

114 funds held ETON in Q2 2026, 60% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of ETONValue% of fundAs of
iShares Russell 2000 ETF694,0132.43%$25.12M0.03%Jun 30, 2026
Vanguard Total Stock Market Index Fund684,8212.40%$24.79M0.00%Jun 30, 2026
Oberweis Micro-Cap Fund483,9001.69%$17.52M1.08%Jun 30, 2026
Fidelity Small Cap Index Fund291,8981.02%$13.55M0.04%Jul 31, 2026
Vanguard Extended Market Index Fund271,0790.95%$9.81M0.01%Jun 30, 2026
Nuveen Quant Small Cap Equity Fund253,3800.89%$11.76M0.29%Jul 31, 2026
Fidelity Small Cap Growth Fund252,9600.88%$11.74M0.13%Jul 31, 2026
iShares Russell 2000 Growth ETF246,4530.86%$8.92M0.06%Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF154,4340.54%$5.59M1.30%Jun 30, 2026
Fidelity Small Cap Growth K6 Fund131,9800.46%$6.13M0.13%Jul 31, 2026
Vanguard Russell 2000 Index Fund131,6340.46%$4.01M0.02%May 31, 2026
Fidelity Extended Market Index Fund119,4500.42%$3.64M0.01%May 31, 2026
Wasatch Micro Cap Fund91,9240.32%$3.33M0.49%Jun 30, 2026
iShares Micro-Cap ETF89,7430.31%$3.25M0.21%Jun 30, 2026
Fidelity SAI Small-Mid Cap Momentum Index Fund70,4610.25%$3.27M0.08%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Sean BrynjelsenPresident & CEO, Director1,029,8493.60%Aug 20, 2026
Ipek Erdogan-TrinkausChief Commercial Officer4,0810.01%Nov 12, 2026
David KrempaChief Business Officer43,3810.15%Oct 6, 2026
Danka RadosavljevicChief Operating Officer22,4730.08%Aug 12, 2026
Judith M. MatthewsChief Financial Officer––Aug 4, 2026
James R. GruberChief Financial Officer213,4200.75%Jan 14, 2026
Charles J. CasamentoDirector0–Nov 10, 2026
Paul V. MaierDirector73,3580.26%Aug 31, 2026
Jennifer McKie AdamsDirector0–Aug 4, 2026
Norbert G. RiedelDirector204,6450.72%Aug 4, 2026
Management Inc. Opaleye10% owner2,705,0009.46%Jul 17, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Ipek Erdogan-Trinkaus
Chief Commercial Officer
Nov 10, 2026Sale−1,160$67.88$78.74K4,081
Ipek Erdogan-Trinkaus
Chief Commercial Officer
Nov 10, 2026Sale−2,340$67.18$157.20K5,241
Ipek Erdogan-Trinkaus
Chief Commercial Officer
Nov 10, 2026Option exercise+3,500$15.47$54.15K7,581
Charles J. Casamento
Director
Nov 10, 2026Sale−2,903$67.87$197.03K0
Charles J. Casamento
Director
Nov 10, 2026Sale−33,956$67.11$2.28M2,903
Charles J. Casamento
Director
Nov 10, 2026Sale−22,601$66.26$1.50M36,859
Charles J. Casamento
Director
Nov 10, 2026Sale−14,715$65.32$961.26K59,460
Charles J. Casamento
Director
Nov 10, 2026Sale−6,380$64.33$410.42K74,175
Charles J. Casamento
Director
Nov 10, 2026Option exercise+21,000$3.78$79.38K80,555
Charles J. Casamento
Director
Nov 10, 2026Option exercise+19,655$8.61$169.23K59,555
Charles J. Casamento
Director
Nov 10, 2026Option exercise+27,400$3.58$98.09K39,900
Charles J. Casamento
Director
Nov 10, 2026Option exercise+12,500$7.31$91.38K12,500
David Krempa
Chief Business Officer
Oct 6, 2026Sale−4,166$55.07$229.41K43,381
David Krempa
Chief Business Officer
Oct 2, 2026Option exercise+10,522––47,547
Paul V. Maier
Director
Aug 28, 2026Sale−36,387$58.64$2.13M73,358
Paul V. Maier
Director
Aug 28, 2026Option exercise+50,000$3.78$189.00K109,745
Paul V. Maier
Director
Aug 28, 2026Sale−128$61.77$7.91K59,745
Paul V. Maier
Director
Aug 28, 2026Sale−13,485$60.21$811.93K59,873
Paul V. Maier
Director
Aug 28, 2026Option exercise+12,500$7.31$91.38K72,245
Paul V. Maier
Director
Aug 28, 2026Sale−36,387$58.64$2.13M73,358
Paul V. Maier
Director
Aug 28, 2026Sale−13,485$60.21$811.93K59,873
Paul V. Maier
Director
Aug 28, 2026Sale−128$61.77$7.91K59,745
Paul V. Maier
Director
Aug 28, 2026Option exercise+50,000$3.78$189.00K109,745
David Krempa
Chief Business Officer
Aug 24, 2026Sale−25,000$65.07$1.63M37,025
David Krempa
Chief Business Officer
Aug 24, 2026Option exercise+25,000$7.31$182.75K62,025
Sean Brynjelsen
President & CEO, Director
Aug 20, 2026Sale−47,307$60.17$2.85M1,004,909
Sean Brynjelsen
President & CEO, Director
Aug 20, 2026Sale−36,373$61.11$2.22M968,536
Sean Brynjelsen
President & CEO, Director
Aug 20, 2026Sale−7,342$62.12$456.09K961,194
Sean Brynjelsen
President & CEO, Director
Aug 19, 2026Sale−8,978$62.65$562.47K1,052,216
Management Inc. Opaleye
10% owner
Jul 14, 2026Sale−15,000$37.54$563.10K2,665,000
Management Inc. Opaleye
10% owner
Jul 14, 2026Sale−13,315$37.54$499.85K40,000
Management Inc. Opaleye
10% owner
Jul 14, 2026Sale−13,315$37.54$499.85K40,000
Management Inc. Opaleye
10% owner
Jul 14, 2026Sale−15,000$37.54$563.10K2,665,000
Sean Brynjelsen
President & CEO, Director
Jul 14, 2026Option exercise+200,000$1.37$274.00K1,061,194
Sean Brynjelsen
President & CEO, Director
Jul 12, 2026Option exercise+27,500––861,194
David Krempa
Chief Business Officer
Jul 12, 2026Option exercise+10,000––37,025
Management Inc. Opaleye
10% owner
Jul 7, 2026Sale−6,685$38.37$256.50K53,315
Management Inc. Opaleye
10% owner
Jul 7, 2026Sale−20,000$38.37$767.40K2,680,000
Management Inc. Opaleye
10% owner
Jul 6, 2026Sale−10,000$38.00$380.00K2,700,000
Management Inc. Opaleye
10% owner
Jul 2, 2026Sale−65,000$37.39$2.43M2,710,000
Management Inc. Opaleye
10% owner
Jul 2, 2026Sale−25,000$37.39$934.75K60,000
Jennifer McKie Adams
Director
Jun 17, 2026Sale−50,000$32.48$1.62M0
Jennifer McKie Adams
Director
Jun 17, 2026Option exercise+50,000$3.78$189.00K50,000
Sean Brynjelsen
President & CEO, Director
May 28, 2026Sale−119,852$31.88$3.82M833,842
Sean Brynjelsen
President & CEO, Director
May 28, 2026Sale−148$32.67$4.84K833,694
David Krempa
Chief Business Officer
May 27, 2026Sale−19,679$31.47$619.30K25,249
David Krempa
Chief Business Officer
May 27, 2026Option exercise+7,203$3.58$25.79K44,928
David Krempa
Chief Business Officer
May 27, 2026Option exercise+12,476$1.37$17.09K37,725
David Krempa
Chief Business Officer
May 26, 2026Sale−37,524$31.49$1.18M25,249
David Krempa
Chief Business Officer
May 26, 2026Option exercise+12,524$1.37$17.16K62,773
David Krempa
Chief Business Officer
May 26, 2026Option exercise+25,000$1.38$34.50K50,249
David Krempa
Chief Business Officer
May 22, 2026Option exercise+30,591$3.58$109.52K68,046
David Krempa
Chief Business Officer
May 22, 2026Sale−32,963$33.22$1.10M35,083
David Krempa
Chief Business Officer
May 22, 2026Sale−519$35.00$18.17K25,249
David Krempa
Chief Business Officer
May 22, 2026Sale−9,315$33.88$315.59K25,768
Norbert G. Riedel
Director
Apr 21, 2026Option exercise+12,500$7.31$91.38K47,500
Norbert G. Riedel
Director
Apr 21, 2026Option exercise+19,655$8.61$169.23K67,155
Norbert G. Riedel
Director
Feb 3, 2026Option exercise+30,000$4.42$132.60K35,000
James R. Gruber
Chief Financial Officer
Jan 14, 2026Tax withholding−2,293$15.47$35.47K213,420
David Krempa
Chief Business Officer
Jan 14, 2026Tax withholding−1,942$15.62$30.33K630,238

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
7.36%
2M shares short
Days to cover
5.4
At 0M shares a day
Change since last report
+2.2%
From 2M shares
Short volume, 20 days
62.6%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Eton Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 816 shares on Aug 24, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Charles J. Casamento
Director
Nov 10, 202680,555$5.34MNov 10, 2026grant
Ipek Erdogan-Trinkaus
Officer
Nov 10, 20263,500$235.94KNov 10, 2026GRANT
David Krempa
Officer
Oct 6, 20264,166$229.41KOct 6, 2026RSU Vest
Paul V. Maier
Director
Aug 28, 202650,000$2.95MAug 28, 2026stock options
David Krempa
Officer
Aug 24, 202625,000$1.63MAug 24, 2026Stock Option Exercise
Sean Brynjelsen
Officer, Director
Aug 20, 2026100,000$6.34MAug 19, 2026founder shares
Sean Brynjelsen
Director, 10% Stockholder
Aug 19, 2026100,000$6.34MAug 19, 2026Founder Shares
James R. Gruber
Officer
Jun 26, 2026251,818$8.99MJun 26, 2026Stock Option Exercies
James R. Gruber
Officer
Jun 25, 202625,000$875.25KJun 25, 2026Stock Option Exercise
James R. Gruber
Officer
Jun 23, 202625,000$830.87KJun 23, 2026Stock Option Exercise
Jennifer McKie Adams
Director
Jun 17, 202650,000$1.62MJun 17, 2026Stock Options
James R. Gruber
Officer
Jun 2, 20263,117$84.16KJun 2, 2026RSU
Sean Brynjelsen
Director
May 28, 2026120,000$3.89MMay 28, 2026Founder Shares
David Krempa
Officer
May 22, 2026100,000$3.50MMay 22, 2026RSU
David Krempa
Officer
Jan 14, 20261,942$30.33KJan 14, 2026Grant

See a number that looks wrong?